FDA docket watch

A cleaner read on public FDA warning letters and recall signals.

FDA Warning Monitor turns public FDA source records into a delayed public archive, category notes, issue tags, and a free weekly enforcement digest.

Public archive: two weeks delayed

Public pages show a 7 to 14 day historical window, not the live source stream. The weekly archive is curated so readers can spot patterns at a glance.

Current staged cutoff: records through April 30, 2026.

Future premium: Live Desk

Live Desk adds: same-day FDA feed, category filters, saved watchlists, alert emails, CSV export, full archive search, and weekly briefs by product lane.

Join the Live Desk waitlist

Delayed public archive

Signals through April 30

Newer source hits stay off public pages for roughly two weeks. The public archive favors reviewed patterns over same-day noise.

Apr 30
CareFusion 213, LLCWarning letter

Public warning-letter record. Category review should focus on device quality and source-linked issue tags before publication.

FDA source

Apr 29
Leading Pharma, LLCDrug recall

Class II recall signal tied to CGMP deviation language and nitrosamine impurity limits.

FDA source

Apr 29
Medline Industries, LPDevice recall

Class II device recall signal tied to 510(k) clearance and design-change language.

FDA source

Warning letters

Company, issue date, FDA link, product lane, and short public note.

Recall signals

Public recall records where source text points to recurring product-control, software, contamination, or labeling themes.

Issue tags

CGMPdevice softwareallergensimportsonline claims

Site boundary: The site organizes public FDA source material and links back to the source record. Full legal and affiliation boundaries live on the About page, not at the end of every post.